AEMETIS, INC Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Aemetis, Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • Aemetis, Inc Operating Income (Loss) for the quarter ending June 30, 2024 was -$13.6M, a 74.7% decline year-over-year.
  • Aemetis, Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$40.6M, a 12% decline year-over-year.
  • Aemetis, Inc annual Operating Income (Loss) for 2023 was -$37.4M, a 8.72% decline from 2022.
  • Aemetis, Inc annual Operating Income (Loss) for 2022 was -$34.4M, a 117% decline from 2021.
  • Aemetis, Inc annual Operating Income (Loss) for 2021 was -$15.8M, a 161% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$37.4M -$3M -8.72% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 -$34.4M -$18.6M -117% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 -$15.8M -$9.76M -161% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 -$6.07M -$1.14M -23.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 -$4.93M +$6M +54.9% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-10
2018 -$10.9M +$1.26M +10.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 -$12.2M -$11.4M -1460% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-15
2016 -$781K +$7.83M +90.9% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-29
2015 -$8.61M -$32.7M -136% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-17
2014 $24.1M +$21.6M +871% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-29
2013 $2.48M +$23.6M Jan 1, 2013 Dec 31, 2013 10-K 2015-03-12
2012 -$21.2M -$16.7M -370% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
2011 -$4.51M +$649K +12.6% Jan 1, 2011 Dec 31, 2011 10-K 2013-04-16
2010 -$5.15M Jan 1, 2010 Dec 31, 2010 10-K 2012-10-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.